| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.8M | — |
| Cost of Revenue | $4.7M | — |
| R&D Expense | $86.7M | +5.8% |
| SG&A Expense | $34.8M | +15.0% |
| Operating Income | -$118.4M | -5.6% |
| Net Income | -$116.7M | -5.8% |
| EPS (Basic) | -$6.85 | -109.5% |
| EPS (Diluted) | -$6.85 | -109.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $24.9M | -79.2% |
| Inventory | $13.6M | — |
| Current Assets | $47.8M | -63.5% |
| Total Assets | $154.5M | -31.6% |
| Current Liabilities | $18.9M | +3.9% |
| Long-term Debt | $11.0M | — |
| Total Liabilities | $48.9M | +164.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$102.0M | -4.0% |
| Capital Expenditures | $7.9M | -83.6% |
| Investing Cash Flow | -$29.1M | +39.6% |
| Financing Cash Flow | $36.5M | -58.4% |
| Free Cash Flow | -$109.9M | +24.8% |
| Stockholders' Equity |
| $105.5M |
| -49.1% |